AVTR Logo

Avantor, Inc. (AVTR) 

NYSE
Market Cap
$14.44B
Sector
Basic Materials
Industry
Chemicals—Specialty
Rank in Sector
118 of 151
Rank in Industry
43 of 54

Largest Insider Buys in Sector

AVTR Stock Price History Chart

AVTR Stock Performance

About Avantor, Inc.

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial …

Insider Activity of Avantor, Inc.

Over the last 12 months, insiders at Avantor, Inc. have bought $0 and sold $1.05M worth of Avantor, Inc. stock.

On average, over the past 5 years, insiders at Avantor, Inc. have bought $544,479 and sold $1.24B worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 15,000 shares for transaction amount of $314,250 was made by Stubblefield Michael (CEO) on 2022‑11‑16.

List of Insider Buy and Sell Transactions, Avantor, Inc.

2024-09-05SaleSVP & Chief Accounting Officer
3,525
0.0005%
$25.06$88,337-11.02%
2024-07-31SaleEVP, AMEA
100
<0.0001%
$28.00$2,800-5.36%
2024-07-30SaleEVP, AMEA
10,000
0.0014%
$27.00$270,000-1.85%
2024-03-08SaleSVP & Chief Accounting Officer
3,685
0.0005%
$25.63$94,447-3.36%
2024-02-29SaleEVP Sales, Customer Excellence
4,910
0.0007%
$24.52$120,393+0.59%
2024-02-29SaleEVP, AMEA
13,074
0.0019%
$24.53$320,705+0.59%
2024-02-27SaleEVP Sales, Customer Excellence
6,203
0.0009%
$24.49$151,911+1.50%
2023-09-07SaleSVP & Chief Accounting Officer
7,577
0.0011%
$20.64$156,389+11.64%
2023-08-25SaleEVP, Americas and Europe
25,000
0.0036%
$21.47$536,750+4.92%
2023-04-11SaleEVP, AMEA
1,498
0.0002%
$21.18$31,728-2.41%
2023-03-03SaleEVP, Biopharma Production
3,914
0.0006%
$25.00$97,850-16.53%
2023-02-28SaleEVP, AMEA
2,324
0.0003%
$24.32$56,520-14.03%
2023-02-27SaleEVP, Biopharma Production
3,059
0.0005%
$25.00$76,475-13.86%
2023-02-23SaleEVP, AMEA
3,078
0.0004%
$24.24$74,611-14.80%
2023-02-22SaleEVP, AMEA
19,160
0.0028%
$24.12$462,139-13.25%
2023-02-02SaleEVP, Biopharma Production
11,339
0.0017%
$25.06$284,155-15.80%
2022-11-16PurchaseCEO
15,000
0.0023%
$20.95$314,250+1.75%
2022-11-16PurchaseEVP & CFO
12,500
0.0019%
$20.71$258,850+1.75%
2022-05-23SaleEVP, Americas & Europe
39,000
0.0061%
$31.61$1.23M-30.23%
2022-05-20SaleEVP, Biopharma Production
19,603
0.003%
$31.27$612,986-29.16%

Insider Historical Profitability

30.13%
Connolly Thomas
58881710
8.6513%
$21.2178+6.56%
GOLDMAN SACHS & CO. LLC
43483708
6.3889%
$21.211719+37.47%
Natauri Jodirector
557656
0.0819%
$21.211820+35.53%
Stubblefield MichaelCEO
429500
0.0631%
$21.2116+1.75%
Szlosek Thomas AEVP & CFO
35668
0.0052%
$21.2110+1.75%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$1.65B9.4964.45M-1.37%-$22.82M0.03
Dodge & Cox$1.63B9.3863.68M+4.06%+$63.52M0.95
T Rowe Price Investment Management Inc$1.31B7.5251.1M-2.97%-$40.02M0.8
BlackRock$1.09B6.342.76M-6.73%-$78.89M0.02
Boston Partners$729.3M4.2128.56M+2.23%+$15.94M0.87
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.